Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000181

Drug Information
SynonymsPrestwick_573; HMS1920H22; Akten; D00127; Riacen; Pyroxycam; CHEBI:8249; AC-12216; Roxiden; Artroxicam; BRN 0627692; HMS2092A05; Erazon; AC1Q3XLJ; 4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Felden; CHEMBL527; Feldene Fast; Roxicam; Geldene; (4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide; 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1; CP 16171; Piroxicamum [INN-Latin]; Piroflex; BAS 04381594; LS-7663; 36322-90-4; piroxicam; Bio-0759; Caliment; CCRIS 3719; HMS1792D11; Apo-Piroxicam; CHF 1251; HMS1990D11; Flogobene; EINECS 252-974-3; 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Reudene; STK177288; BAXO; Piroftal; AK1015; Larapam; UNII-13T4O6VMAM; D010894; Pirkam; Zunden; 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid; NSC666076; CP-16171; CP16171; EU-0100900; C01608; 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; S1713_Selleck; DB00554; HMS1362D11; Piroxicam [USAN:BAN:INN:JAN]; Feldene Gel; Solocalm; Piroxicam (JP15/USP/INN); Bruxicam; P0847_SIAL; 4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide; AC1NQX1P; Feldene, Roxam, Piroxicam; Improntal; P 5654; HMS1568L03; Pipoxicam; 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide; C15H13N3O4S; MolPort-001-888-120; 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German]; Feldene (TN); Feldene; (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1; piroxicam usp; CID5280452; NSC 666076; SPECTRUM1500491; Sasulen; HMS501C11; 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; AKOS000714958; Piroxicamum    
Trade NameFeldene; Brexidol; Brexin; Erazon; Exipan; Felden; Feldoral; Hotemin; Pirox von ct; Proponol; Reumador; Tracam; Veral; Mobilis; Vurdon    
CompanyPfizer Pharmaceuticals    
IndicationPainApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnalgesics    
CAS NumberCAS 36322-90-4
PubChem Compound IDCID 5280452.    
PubChem Substance IDSID 4761.    
SuperDrug ATC IDM01AC01;    
SuperDrug CAS ID036322904;    
TargetProstaglandin G/H synthase 2Inhibitor[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 073535 To Reference
Ref 2Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development. Reprod Toxicol. 2009 Sep;28(2):239-44. Epub 2009 Apr 18. To Reference
Ref 3The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids. Pain. 2009 Mar;142(1-2):94-100. Epub 2009 Jan 30. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543